Sysmex Hisse

Sysmex EBITDA

Sysmex (6869.T) öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 25 Ağu 2026 itibarıyla 90,35 Md JPY dir. Önceki yılda, EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) 80,06 Md JPY idi — 12,86% (daha yüksek) bir değişiklik.

EBITDA

90,35 MdJPY

YoY

12,86%

Son güncelleme:

Sysmex öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 90,35 Md JPY dir. Sysmex öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2025 80,06 Md JPY idi. %12,86 daha yüksek önceki yıla kıyasla azalmaktadır.

Sysmex EBITDA Tarihçesi

  • 3 yıl

  • 10 yıl

  • 25 Yıl

  • Maks.

EBITDA
Date
EBITDA
1 Oca 2018
60,01 Md JPY
1 Oca 2019
61,43 Md JPY
1 Oca 2020
54,89 Md JPY
1 Oca 2021
49,86 Md JPY
1 Oca 2022
68,95 Md JPY
1 Oca 2023
73,99 Md JPY
1 Oca 2024
80,06 Md JPY
1 Oca 2025
90,35 Md JPY
Sysmex EBITDA Tarihçesi
YILEBITDAYoY
90,35 MdJPY+12,86%
80,06 MdJPY+8,19%
73,99 MdJPY+7,31%
68,95 MdJPY+38,28%
49,86 MdJPY-9,16%
54,89 MdJPY-10,65%
61,43 MdJPY+2,37%
60,01 MdJPY+15,59%
51,92 MdJPY-15,00%
61,08 MdJPY+27,12%
48,05 MdJPY+33,96%
35,87 MdJPY
Access this data via the Eulerpool API

Sysmex Hisse senedi analizi

Sysmex ne yapar? Sysmex Corp is a Japanese company that has been a leading provider of diagnostic and analytical laboratory systems and solutions for the healthcare industry since its founding in 1968. The company is headquartered in Kobe, Japan and employs over 9,000 people worldwide. History: Sysmex was founded by a group of young scientists in Japan who wanted to develop an automated blood cell analysis system to improve the high workload of manual blood analysis at the time. The company began developing this system and brought it to market in 1972. Business model: Sysmex focuses on the development, production, and sale of diagnostic systems and solutions for medical laboratories around the world. The company specializes in hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology. Divisions: Sysmex Corp is divided into three main business divisions: 1. Diagnostic Systems: This division includes hematology, hemoglobinopathy, hemostasis, urinalysis, immunology, clinical chemistry, and molecular biology systems. Sysmex is one of the world's leading providers of hematology analysis devices and also offers molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. 2. Information Solutions: This division offers software and IT solutions that support laboratory management and the integration of laboratory data to optimize analysis processes. The company also offers solutions for automating laboratory processes and managing laboratory inventory. 3. Life Science: This division focuses on the development of products for the life sciences, particularly cell analysis and imaging, as well as production, processing, and storage of cell cultures. Sysmex is also involved in the production of devices for harvesting mesenchymal stem cells from adipose tissue. Products: Sysmex offers a variety of products, including: - Hematology analysis devices for determining blood cell parameters such as RBC, WBC, HGB, HCT, and platelets. - Hemostasis systems for analyzing blood coagulation. - Molecular biology systems for the diagnosis and monitoring of infectious diseases and cancer. - Urinalysis systems for analyzing urine samples for chemical and microscopic parameters. - Immunology analysis devices for determining specific proteins and antibodies in the blood. - Clinical chemistry analysis devices for analyzing chemical parameters in blood samples. - Software and IT solutions for optimizing laboratory processes and management. - Cell analysis and imaging systems for investigating cell morphology and functions. - Devices for harvesting mesenchymal stem cells from adipose tissue. In summary, Sysmex Corp is a global leader in diagnostic and analytical laboratory systems and solutions for the healthcare industry. In its nearly 50-year history, the company has developed and produced a wide range of products that enable laboratories to perform fast and accurate disease diagnosis. The company has also expanded its business into other areas such as information solutions and the life sciences. Sysmex, Eulerpool'daki en popüler şirketlerden biridir.

Sysmex hisse senedi hakkında sık sorulan sorular

Sysmex şirketinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 2026 yılında 90,35 Md JPY.

Sysmex öğesinin EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) değeri 80,06 Md JPY değerinden 90,35 Md JPY değerine değişmiş ve bu %12,86 değişimi temsil etmektedir. Değer önceki yıldan daha yüksek dir.

Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr) öğesinin Sysmex değerinin 2006'dan itibaren tam tarihsel gelişimini bulabilirsiniz — yıllık değerler, grafikler ve ayrıntılı analiz ile.

EBITDA, finansal yapı, vergi ortamı ve nakit olmayan amortisman giderleri etkisinden önceki işletme performansını ölçer.

EBITDA = EBIT + Amortisman

EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin JPY, yatırımcılar için kilit bir faktördür. Bu metrikte yapılan değişiklikler temel faktörlerin iyileşmesini veya kötüleşmesini gösterebilir ve hisse senedi fiyatını doğrudan etkiler. Eulerpool'da EBITDA (Faiz, Vergi, Amortisman Öncesi Kâr)'nin Sysmex değerini tarihsel olarak ve gerçek zamanlı olarak takip edebilirsiniz.

Access this data via the Eulerpool API

Gelir Tablosu — Sysmex

Tüm Kilit Metrikler — Sysmex